n-(gamma-maleimidobutyryloxy)succinimide has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
| Studies (n-(gamma-maleimidobutyryloxy)succinimide) | Trials (n-(gamma-maleimidobutyryloxy)succinimide) | Recent Studies (post-2010) (n-(gamma-maleimidobutyryloxy)succinimide) | Studies (arginyl-glycyl-aspartyl-serine) | Trials (arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (arginyl-glycyl-aspartyl-serine) |
|---|---|---|---|---|---|
| 19 | 0 | 4 | 503 | 0 | 79 |
| Protein | Taxonomy | n-(gamma-maleimidobutyryloxy)succinimide (IC50) | arginyl-glycyl-aspartyl-serine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 4.17 | |
| Integrin beta-1 | Homo sapiens (human) | 2.2 | |
| Integrin alpha-IIb | Homo sapiens (human) | 4.17 | |
| Integrin alpha-5 | Homo sapiens (human) | 2.2 | |
| Integrin beta | Oryctolagus cuniculus (rabbit) | 5.1 | |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baloun, J; Doubek, M; Horák, D; Plichta, Z; Pospíšilová, Š; Proks, V; Studená, R; Svozilová, H | 1 |
1 other study(ies) available for n-(gamma-maleimidobutyryloxy)succinimide and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model.
Topics: Cell Culture Techniques; Cell Line, Tumor; Humans; Hydrogels; Leukemia, Lymphocytic, Chronic, B-Cell; Mesenchymal Stem Cells; Oligopeptides; Porosity; Succinimides; Tissue Scaffolds | 2021 |